Confirmatory Dose Finding Study of 2 Dosages of CHF 4226 pMDI (Carmoterol) in Patients With COPD

NCT00640484 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

57

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Obstructive Pulmonary Disease

Interventions

DRUG: carmoterol (CHF 4226)
DRUG: carmoterol (CHF 4226)
DRUG: placebo
DRUG: salmeterol

Sponsor

Chiesi Farmaceutici S.p.A.